Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care

综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学

• 批准号: 9110938
• 负责人: Bruce R Schackman
• 金额: $ 112.7万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-15 至 2020-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9110938
• 关键词: Address; Affordable Care Act; Alcohol or Other Drugs use; American; Award; Caring; Clinical; Clinical Trials; Collaborations; Communication; Consultations; Costs and Benefits; Data; Data Collection; Development; Discipline; Economics; Ensure; Environment; Feedback; Funding; Grant; HIV; HIV/HCV; Health; Health Insurance; Health Personnel; Healthcare; Healthcare Systems; Hepatitis C virus; Individual; Institution; Insurance Carriers; Insurance Coverage; Intervention; Leadership; Location; Mental Health; Mentors; Mentorship; Methodology; Methods; Modeling; Observational Study; Online Systems; Organizational Models; Pattern; Persons; Pharmaceutical Preparations; Policies; Process; Provider; Research; Research Infrastructure; Research Personnel; Research Project Grants; Resources; Self-Examination; Services; Staging; Structure; Substance Use Disorder; System; Technology; Time; Training; Training Activity; Translating; United States National Institutes of Health; Work; advanced simulation; career development; cohort; economic evaluation; economic impact; economic need; experience; health economics; improved; innovation; meetings; novel; outreach; parity; public health relevance; ranpirnase; research data dissemination; screening; simulation; skills; sound; tool; training opportunity; treatment strategy

 DESCRIPTION (provided by applicant): The US healthcare system is evolving towards a more integrated approach to improving the health of Americans. Greater availability of health insurance through the Affordable Care Act and new organizational models such as integrated healthcare systems are leading health care providers and insurers to consider the totality of costs and benefits, instead of focusing on costs and benefits of individual service delivery "silos." For substance users, parity requirements for substance use disorder (SUD) and mental health insurance coverage and health insurance expansion present new opportunities for integrated care. They also present new opportunities and challenges for treating HCV-infected and HIV-infected substance users with highly effective and expensive medications. Both the broad societal economic impact and the health economic benefits for individuals of SUD, HCV, and HIV treatment need to be evaluated and communicated to clinical and policy decision makers in the context of this new environment. The overall specific aim of our P30 Center of Excellence proposal entitled "Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care" is to develop and disseminate economic evidence that informs substance use treatment policy and HCV and HIV care of substance users, and to increase the impact of this research by addressing the needs of integrated healthcare system providers and payers. Our proposed Center (CHERISH: Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV) includes Methodology, HCV and HIV, Dissemination and Policy, Pilot Grant and Training, and Administrative Cores, a Policy Advisory Board, and a Center Advisory Board. The Core leaders and investigators have extensive experience with multi-institutional collaborations and several previous and ongoing collaborations. They will draw on a wider circle of experts involved with each of the NIH-supported research projects. CHERISH will be led by an established national expert in SUD, HCV, and HIV health economic research who has substantial management experience. We will innovatively use web-based technology to supplement frequent in-person meetings and support a structured management process and administrative tracking system. The proposed Center will serve as a national SUD health economics research resource, furthering scientific collaborations among researchers, providing feedback to these researchers from stakeholders, and conducting outreach to clinical and policy decision makers. Such interaction between researchers and decision makers is essential for NIH-funded research on SUD treatment strategies to have its greatest impact. Through pilot grants and associated training activities, we will provide new opportunities for training, mentoring and career development for researchers in the field of SUD, HCV, and HIV health economics. These activities will yield a new cohort of investigators with the skills needed to conduct methodologically sound and innovative SUD economic research to inform SUD, HCV, and HIV treatment policy.

 描述（由申请人提供）：美国医疗保健系统正在发展更加集成的Apploch，以改善美国人的健康状况。成本和收益，而不是专注于服务用户的成本和收益，而是对物质使用障碍的均等要求（SUD）和心理健康保险范围和健康保险表达方式。在此WEW环境中，需要评估HCV感染的HIVSTANCE用户，并需要评估一些临床和政策决策者。在综合医疗保健时代的治疗“是为了开发和传播证据，以告知物质使用治疗政策和HIVSTANCE使用者，以增加对综合医疗保健系统提供者和付款人需求的解决的影响。 ，HCV和HIV）包括方法，纪律和传播以及奥利利，飞行员赠款和培训以及行政核心，政策顾问委员会以及中心顾问委员会。在涉及SUD的研究项目中，艾滋病毒卫生经验的研究很大，我们将在技术上有创新的技术。经济学的研究人员，为研究人员提供反馈，并为研究人员提供反馈SUD，HCV和HIB健康经济学领域。